当前位置: 首页 » 职称论文 » 医药卫生 » 正文
PDCA循环在控制药品费用中的应用
发布日期:2021-06-15     浏览次数:33
核心提示:摘要目的评价计划—实施—检查—处理(PDCA)循环管理方法在控制药品费用中的应用效果。方法应用PDCA循环管理方法完善重点监控药品和辅助用药管控制度、
 
摘要 目的评价计划—实施—检查—处理(PDCA)循环管理方法在控制药品费用中的应用效果。方法应用PDCA循环管理方法完善重点监控药品和辅助用药管控制度、开展处方点评新模式、落实处方点评结果、信息系统限制等措施,比较2018年(PDCA执行前)和2019年(PDCA执行后)就诊患者人均药费及门诊和住院药品销售金额。结果执行PDCA循环管理方法后,门诊人均就诊药费由113.0元下降至110.2元,住院人均就诊药费由1 476.5元下降至1 414.5元,实现患者人均药费增幅不超过5%的目标。门诊药品销售金额由4 094.3万元下降至4 328.5万元,住院药品销售金额由4 212.2万元下降至4 409.1万元,实现药品销售金额增长不超过8%的目标。结论 PDCA循环管理方法可有效控制药品费用不合理增长。 Objective To evaluate the effect of plan-do-check-act( PDCA) cycle management method on controlling the drug costs. Methods PDCA cycle management method was applied to improve the control system of key monitored drugs and auxiliary drugs,develop the new model of prescription review,implement the result of prescription review,and restrict the information system,and other measures,so as to compare the per capita drug cost of patients in 2018( before PDCA implementation) and 2019( after PDCA implementation). Results After the implementation of PDCA cycle management method,the drug fee per outpatient per capita decreased from 113. 0 yuan to 110. 2 yuan,and the drug fee per inpatient per capita decreased from 1 476. 5 yuan to 1 414. 5 yuan,achieving the target of no more than 5% increase in the drug fee per patient per capita. The sales amount of outpatient drugs decreased from 40. 943 million yuan to 43. 285 million yuan,and the per capita medical expenses of inpatients decreased from 42. 122 million yuan to 44. 091 million yuan,achieving the target of no more than 8% increase in the per capita medical expenses of patients. Conclusion PDCA cycle management method can effectively control the unreasonable increase of drug cost.
作者 刘佳佳 李志金 LIU Jiajia;LI Zhijin(Department of Pharmacy,Hebei Eye Hospital,Hebei Province,Xingtai 054001,China)
出处 《临床合理用药杂志》 2021年第11期38-41,共4页 Chinese Journal of Clinical Rational Drug Use
关键词 PDCA 药品费用管控 合理用药 PDCA Drug cost control Rational use
 
 
 
 

桂IPC备2020008163号-1

(c)2008-2018 理论研究网

 

免责声明:本平台并非任何杂志官网,仅限于整理学术信息以及期刊投稿渠道